<DOC>
	<DOCNO>NCT02403986</DOCNO>
	<brief_summary>A randomised , multi-centre , parallel-group efficacy safety study evaluate two three initial treatment session Restylane Skinboosters Vital Lidocaine face . Approximately 50 female subject shall treat two three initial treatment session include long-term follow-up 18 month initial treatment regimen .</brief_summary>
	<brief_title>An Efficacy Safety Study Evaluating Treatment Sessions Restylane Skinboosters Vital Lidocaine Face</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Provision sign date informed consent participate study . Nonpregnant , nonbreast feed female age 3545 year . Visible sign age face Intent improve skin hydration , skin structure elasticity skin use Restylane Skinboosters Vital Lidocaine . Extensively photo damage age skin . Woman plan become pregnant course study . Known/previous allergy hypersensitivity injectable hyaluronic acid ( HA ) gel . Known/previous allergy hypersensitivity local anaesthetic , e.g . lidocaine amidetype anaesthetic . History severe multiple allergy manifest anaphylaxis . History bleed disorder treatment anticoagulant inhibitor platelet aggregation , Omega3 Vitamin E within 10 day study treatment Treatment chemotherapy , immunosuppressive agent , immunomodulatory therapy ( e.g . monoclonal antibody ) , systemic topical ( facial ) corticosteroid ( inhaled corticoid allow ) within three month study treatment . Previous tissue augment therapy contour permanent filler fatinjection face . Previous tissue augment therapy , contour revitalisation treatment nonpermanent filler , neurotoxin revitalisation preparation ( e.g . Hyal System Restylane Skinboosters ) face within 12 month study treatment . Previous tissue revitalisation treatment laser light , radiofrequency , focus ultrasound , chemical peeling , dermabrasion , mesotherapy similar treatment influence skin quality face within 6 month study treatment . Previous aesthetic facial surgical therapy , liposuction tattoo face . Previous sinus surgery dental root surgery within 3 month study treatment . Active skin disease , inflammation related condition , infection , perioral dermatitis , seborrheic eczema , rosacea , acne , psoriasis herpes zoster face . History active collagen disease autoimmune disease systemic lupus erythematosus , rheumatic arthritis , skin systemic sclerosis . Tendency form keloid , hypertrophic scar heal disorder . History radiation cancerous precancerous lesion ( e.g . actinic keratosis ) face . Use systemic facial topical retinoic acid within 12 month study treatment . Nicotine use within 6 month study treatment . ( Occasional smoking , 15 cigarette per week , similar amount nicotine , allow ) . Any medical condition , opinion Investigator , would make subject unsuitable inclusion ( e.g . chronic , relapse hereditary disease may interfere outcome study . Other condition prevent subject enter study Investigator 's opinion , e.g . subject likely avoid facial aesthetic treatment , subject anticipate unreliable , unavailable incapable understanding study assessment unrealistic expectation treatment result . Study site personnel close relative study site personnel ( e.g . parent , child , sibling spouse ) employee Sponsor company . Participation clinical study within 3 month study treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>